Utah Medical Products, Inc.UTMDNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank33
3Y CAGR-46.3%
5Y CAGR-28.0%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-46.3%/yr
vs +61.6%/yr prior
5Y CAGR
-28.0%/yr
Recent deceleration
Acceleration
-107.9pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.86% |
| Q3 2025 | 0.61% |
| Q2 2025 | 0.42% |
| Q1 2025 | 2.03% |
| Q4 2024 | -2.94% |
| Q3 2024 | 4.19% |
| Q2 2024 | -2.89% |
| Q1 2024 | -0.18% |
| Q4 2023 | 3.73% |
| Q3 2023 | 1.57% |
| Q2 2023 | 3.31% |
| Q1 2023 | 3.12% |
| Q4 2022 | 5.56% |
| Q3 2022 | 1.17% |
| Q2 2022 | -1.23% |
| Q1 2022 | 1.89% |
| Q4 2021 | -2.80% |
| Q3 2021 | 2.41% |
| Q2 2021 | 2.31% |
| Q1 2021 | 1.98% |
| Q4 2020 | 4.45% |
| Q3 2020 | 3.31% |
| Q2 2020 | 2.73% |
| Q1 2020 | -6.16% |
| Q4 2019 | 6.27% |
| Q3 2019 | 1.17% |
| Q2 2019 | 1.91% |
| Q1 2019 | 3.51% |
| Q4 2018 | 0.54% |
| Q3 2018 | 6.50% |
| Q2 2018 | 0.66% |
| Q1 2018 | 6.47% |
| Q4 2017 | -4.03% |
| Q3 2017 | 4.94% |
| Q2 2017 | 6.44% |
| Q1 2017 | 5.25% |
| Q4 2016 | -3.96% |
| Q3 2016 | 1.73% |
| Q2 2016 | -0.95% |
| Q1 2016 | 3.27% |